Atlas Trials

REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease

Clinical trial NCT06936111 · RECRUITING

Trial details

NCT number
NCT06936111
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Coronary Heart Disease (CHD)
Start date
2025-07-01
Primary completion
2027-01-01
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.